Mostafa Kamal talks evolution of PBM industry, latest developments, in Fierce Healthcare panel
Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costsJanuary 30, 2024
Experts explored the issues, changes and challenges impacting the role and influence of PBMs, delving into hot topics such as GLP-1 weight-loss drugs, biosimilars, rising pharmaceutical costs and the future of the PBM industry.
“With the proliferation of technology—artificial intelligence and other tools that we see emerging around us—I think it’s a unique moment in time for us to be able to look at the macro trends, identify significant needs and bring in technology to help us solve and move forward in ways that go beyond what we’ve done historically,” Kamal says, “which is managing unit costs and managing utilization, and move PBMs more toward managing total experiences and affordability and outcomes for patients—total health outcomes.”
Register for free to see the full panel discussion, then click on “Sessions” then “Panel: Pharmacy Benefit Managers: The Evolving Discussion | Closing Remarks.”
February 2, 2024
Prime is committed to closing gaps in cancer care by delivering meaningful oncology solutions to help people living with cancer.
January 24, 2024
Honor demonstrates Prime/MRx’s impact and commitment to delivering diverse and inclusive work environment
January 9, 2024
In this episode, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.